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more effective. The fetus can be discovered in time before birth to
avoid a series of irreversible pathophysiological changes.
Methods: A total of 148 pregnant women who underwent prenatal
ultrasound screening in our hospital from December 2016 to May
2018 were selected. 58 patients with fetal thyroid abnormalities were
selected in the experimental group, and 90 patients with normal fetal
thyroid gland were selected as the control group. Univariate analysis
was used to screen out the factors which can enter the model.
Statistically significant factors of univariate analysis were included
in the regression model for analysis. Logistic regression models were
established based on the (above analysis) results and the ultrasound
image characteristics of the two groups were compared.
Results: Univariate regression analysis showed that there were five
factors in the final model, including maternal thyroid dysfunction
and thyroid surgery history, goiter, thyroid autoantibodies, history
of head and neck radiation, abortion and premature birth history.
Logistic regression analysis showed that the mother who with
above-mentioned five high-risk factors are the main causes of fetal
thyroid dysplasia.
Conclusions: The results of the logistic regression analysis showed
that the proportion of maternal thyroid dysfunction and thyroid
surgery, goiter, thyroid autoantibodies, head and neck radioactivity,
abortion and premature birth risk was significantly higher in the
experimental group than in the observation group (P < 0.05).
Logistic regression analysis showed that the mother who with
above-mentioned five high-risk factors lead to fetal thyroid dysplasia.
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Fetal thymus size in pregnancies after assisted reproductive
technologies
J. Braun1, T.G. Nau1, K. Oelmeier de Murcia1,
M. Moellers1, R. Abhari2, J. Steinhard3, W. Klockenbusch1,
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Objectives: The aim of our study was to compare thymus sizes in
fetuses conceived using assisted reproductive technologies (ART) to
those conceived naturally (control group).
Methods: Sonographic fetal thymus size was assessed retrospec-
tively in 162 pregnancies conceived using ART and in 774 preg-
nancies conceived naturally. The anteroposterior thymic and the
intrathoracic mediastinal diameter were measured to calculate the
thymic–thoracic ratio (TT-ratio). The ART cases were subdivided
into two groups: (1) intracytoplasmic sperm injection (ICSI; n = 109)
and (2) in vitro fertilisation (IVF; n = 53).
Results: The TT-ratio was smaller in pregnancies conceived using
ART (p < 0.001). In both ART subgroups (ICSI and IVF), the
TT-ratio was lower compared to the control group (p < 0.001).
However, no difference between the two subgroups could be
detected (p = 0.203).
Conclusions: Our data show reduced thymus size in fetuses
conceived using ART compared to controls. These findings indicate
that the use of ART may lead to certain deviations in organogenesis.
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Antenatal diagnosis of Diamond-Blackfan anemia
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We report a case of a 31-year-old women G2P1 refered to
our high-risk centre because of her husband was known for
Diamond-Blackfan anemia. He was followed and treated for this
condition until this age of 14 months of age and has been in remission
since. His father was also affected. He had a genetic evaluation in
2014 and no molecular diagnosis had been made.
The patient’s prenatal screening was normal. No prenatal
diagnosis was offered because of the absence of a known mutation.
The couple met hemato-oncology and started weekly middle cerebral
artery (MCA) Doppler at 16 weeks.
At 33 2/7 weeks, the fetus was found to have MCA peak systolic
of 75 cm/s (1,61 MoM). Signs of hydrops were not reported.
We performed an intrauterine transfusion the next day. The fœtus
had a pre-transfusion hematocrit of 27% and 48ml of blood was
transfused. All the subsequent evaluation were normal and the
patient delivered a baby girl of 2600g, apgar 2-9-9 by Caesarean
section because of breech presentation at 36 4/7 weeks of pregnancy.
Evaluation of the newborn revealed a heterozygote mutation of
the RPS19 gene consistEnt with a diagnostic of Diamond-Blackfan
anemia. This mutation was also confirmed for the father.
Diamond-Blackfan anemia is a disorder that primarily affects the
bone marrow causing it to malfunction and fail to produce enough
red blood cells. It is a rare autosomal dominant pathology with
variable penetrance that affects both genders equally. Over half of
all Diamond-Blackfan anemia patients present with short stature and
congenital anomalies, the most frequent being craniofacial, thumb
and urogenital anomalies. Few cases of in utero Diamond-Blackfan
anemia have been reported.
P06: FETAL GROWTH: PREDICTING
OUTCOMES
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Routine late trimester ultrasound for the detection of
small-for-gestational-age and growth-restricted fetus in
low-risk pregnancy: a randomised controlled trial
S.Z. Wanyonyi, D.M. Osoro, M. Temmerman
Obstetrics and Gynaecology, Aga Khan University Hospital,
Nairobi, Kenya
Objectives: To compare the proportion of small-for-gestational-age
and fetal growth-restricted fetuses detected in women offered a
routine growth ultrasound to those either offered selective or no
ultrasound in the third trimester.
Methods: An open-label randomised control trial was conducted at
the Aga Khan University Hospital, Nairobi. Eligible women were
randomised into either the intervention or control group. Women in
the intervention arm had a mandatory third trimester ultrasound for
fetal growth performed between 36 weeks 0 days to 37 weeks 6 days.
Those in the control group had a selective growth scan done if the
clinician suspected abnormal fetal growth. The women were then
followed up for delivery outcomes. Analysis was on an intention to
treat basis.
Results: A total of 278 women were recruited into the study
with an overall completion rate of 88%. A majority of the
women (67.8%) were primiparous. The overall detection rate of
small-for-gestational-age and fetal growth-restricted fetus in the
intervention groups was 10.9% (95%CI 4.9-16.9) with numbers
needed to treat (NNT) of 9. The detection rate for fetal growth
restriction was 3.6 (95%CI -0.28-7.5) and for small for gestational
age was 4.5 (95% CI 0.29-8.8). The perinatal outcomes were similar
between the two study groups.
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Conclusions: Compared to selective third-trimester ultrasound, rou-
tine growth ultrasound for all low-risk women increased the detec-
tion rate of small-for-gestational-age and growth-restricted fetuses.
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Third trimester ultrasound screening in IVF pregnancies
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Objectives: Pregnancies achieved through in vitro fertilisation (IVF)
are associated with increased perinatal morbidity. The benefits of
antenatal testing in this group are unknown. Our objective was to
determine the incidence of abnormal ultrasound (US) findings in a
cohort of women with IVF pregnancies.
Methods: We conducted a prospective observational study evaluat-
ing our US protocol for IVF pregnancies which includes weekly BPPs
starting at 36 weeks and growth US at 32 and 36 weeks. Records
were reviewed from April 2017 – March 2019. Singleton gestations
conceived with IVF were included. Women with an isolated IVF
pregnancy were compared to those with an IVF pregnancy and a
medical comorbidity*. Outcomes included detection of fetal growth
restriction (FGR), large for gestational age (LGA), oligohydramnios,
polyhydramnios or abnormal BPP (< 8/8).
Results: A total of 272 women with IVF pregnancies received an
US ≥ 32 weeks. Among women with an isolated IVF pregnancy
(n = 205), 8 had FGR (3.9%), 9 had LGA (4.4%), 4 had oligohy-
dramnios (2.0%), 14 had polyhydramnios (6.8%), and 10 had an
abnormal BPP (4.9%). LGA was more common in IVF pregnancies
with additional comorbidities (4.4% vs 16.4%; p = 0.003).
Conclusions: In singleton IVF pregnancies, the detection rates of
FGR, fluid abnormalities, and abnormal BPPs were similar between
those with and without additional comorbidities. Perinatal outcome
data is needed to determine possible benefit of antenatal testing in
this cohort of women.
P06.02: Table 1. Pregnancy complications detected by US in IVF
pregnancies
Characteristic
Isolated
IVF
(n = 205)
IVF with
comorbidities*
(n = 67) p-value
FGR < 10% 8 (3.9) 0 (0) 0.21
LGA > 90% 9 (4.4) 11 (16.4) 0.003
Oligohydramnios 4 (2) 0 (0) 0.58
Polyhydramnios 14 (6.8) 7 (10.4) 0.34
Abnormal BPP 10 (4.9) 7 (10.4) 0.10
Data presented as n (%); *Hypertensive disease and diabetes (all
types)
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Objectives: Obesity is associated with an increased risk of perinatal
complications including stillbirth. The benefits of antenatal testing
in this group are unknown. Our objective was to determine the
incidence of abnormal ultrasound (US) findings in a cohort of
women with class 3 obesity.
Methods: We conducted a prospective observational study eval-
uating our US protocol for class 3 obesity (BMI ≥ 40) which
includes weekly BPPs starting at 36 weeks and growth US at 32 and
36 weeks. Records were reviewed from April 2017–March 2019.
Singleton gestations with class 3 obesity were included. Women
with isolated obesity were compared to those with obesity and a
medical comorbidity*. Outcomes included detection of fetal growth
restriction (FGR), large for gestational age (LGA), oligohydramnios,
polyhydramnios, or abnormal BPP (< 8/8).
Results: A total of 1,096 women with class 3 obesity received
an US ≥ 32 weeks. Among women with isolated class 3 obesity
(n = 658), 18 had FGR (2.7%), 42 had LGA (6.4%), 12 had
oligohydramnios (1.8%), 64 had polyhydramnios (9.7%), and 34
had an abnormal BPP (5.2%). LGA was more common in obese
women with additional comorbidities (6.4% vs 12.3%; p < 0.001).
Conclusions: In class 3 obese women, the detection rates of FGR,
fluid abnormalities, and abnormal BPPs were similar between those
with and without additional comorbidities. Perinatal outcome data
is needed to determine possible benefits of antenatal testing in this
cohort of women.
P06.03: Table 1. Pregnancy complications detected by US in class 3
obesity
Characteristic
Isolated
obesity
(n = 658)
Obesity with
comorbidities*
(n = 438) p-value
FGR < 10% 18 (2.7) 9 (2.1) 0.47
LGA > 90% 42 (6.4) 54 (12.3) < 0.001
Oligohydramnios 12 (1.8) 8 (1.8) 1.00
Polyhydramnios 64 (9.7) 51 (11.6) 0.32
Abnormal BPP 34 (5.2) 32 (7.3) 0.15
Data presented as n (%); *Hypertensive disease and diabetes (all
types)
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Prognostic factors of vaginal delivery after labour induction
of late-onset fetal growth restriction
C. Villalain Gonzalez, I. Herraiz, M.S. Quezada, E. Gómez
Montes, E. Simón, P.I. Gómez-Arriaga, A. Galindo
Obstetrics and Gynecology, Hospital ‘‘12 de Octubre’’,
Madrid, Spain
Objectives: To identify independent risk factors for vaginal delivery
in cases of labour induction for late-onset fetal growth restriction
(FGR) and to elaborate a multivariate predictive model.
Methods: Retrospective cohort study in 201 singleton pregnancies
diagnosed of late-onset stage I FGR that required labour induction
with cervical ripening. Dinoprostone was used between 2014-2015,
while Foley ballon was the method of choice from 2016. We applied
a non-linear transformation to each variable to elaborate a prediction
model. An optimism-corrected estimate of the area under the curve
(AUC) was derived using 1000 bootstrap resamples for internal
validation.
Results: The Caesarean rate was 25.4%. Perinatal results were
better in the vaginal delivery group (table 1). Independent factors
associated to an increase in vaginal delivery were: labour induction
method (Foley balloon), higher cerebro-placental ratio (CPR), lower
pre-gestational BMI and absence of pre-eclampsia. The AUC was of
0.75(CI95% 0.70–0.79). Illustrative examples are shown in figure 1.
© The Authors 2019
170 © Ultrasound in Obstetrics & Gynecology 2019; 54 (Suppl. 1): 155–223.
